HJGA
JAZZ icon

Hardman Johnston Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hardman Johnston Global Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,420
Closed -$1.74M – 79
2020
Q1 		$1.74M Sell
17,420
-18,700
-52% -$2.42M 0.1% 52
2019
Q4 		$5.39M Hold
36,120
– – 0.22% 49
2019
Q3 		$4.63M Buy
36,120
+2,410
+7% +$323K 0.21% 46
2019
Q2 		$4.81M Buy
33,710
+10,770
+47% +$1.45M 0.21% 46
2019
Q1 		$3.28M Sell
22,940
-11,930
-34% -$1.56M 0.14% 49
2018
Q4 		$4.32M Hold
34,870
– – 0.22% 46
2018
Q3 		$5.86M Sell
34,870
-240
-0.7% -$41.3K 0.25% 46
2018
Q2 		$6.05M Sell
35,110
-1,350
-4% -$221K 0.26% 45
2018
Q1 		$5.5M Sell
36,460
-1,340
-4% -$197K 0.23% 46
2017
Q4 		$5.09M Sell
37,800
-5,780
-13% -$802K 0.22% 47
2017
Q3 		$6.37M Sell
43,580
-610
-1% -$92.3K 0.27% 47
2017
Q2 		$6.87M Sell
44,190
-1,690
-4% -$258K 0.3% 51
2017
Q1 		$6.66M Sell
45,880
-260
-0.6% -$33.9K 0.3% 51
2016
Q4 		$5.03M Hold
46,140
– – 0.25% 52
2016
Q3 		$5.61M Buy
46,140
+580
+1% +$78.2K 0.26% 52
2016
Q2 		$6.44M Buy
45,560
+210
+0.5% +$31K 0.33% 53
2016
Q1 		$5.92M Buy
+45,350
New +$5.64M 0.35% 51

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Hardman Johnston Global Advisors's JAZZ Position: Q2 2020 in Review

Hardman Johnston Global Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 17,420 shares — an estimated $1.74M sold.

Hardman Johnston Global Advisors first reported a position in JAZZ in Q1 2016 and held it in 17 quarters. The position peaked at $6.87M in Q2 2017. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • Hardman Johnston Global Advisors reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Hardman Johnston Global Advisors sold 17,420 Jazz Pharmaceuticals shares in Q2 2020, an estimated $1.74M.
  • Hardman Johnston Global Advisors first reported a position in Jazz Pharmaceuticals in Q1 2016 and held it in 17 quarters.
  • Hardman Johnston Global Advisors's Jazz Pharmaceuticals position peaked at $6.87M in Q2 2017.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Hardman Johnston Global Advisors's 13F filing for Q2 2020, filed 23 Jul 2020.